Clinical Trials Directory

Trials / Completed

CompletedNCT01365234

Model 20066 Left Ventricular (LV) Lead Study

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
40 (actual)
Sponsor
Medtronic Cardiac Rhythm and Heart Failure · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Heart failure is a progressive disease that decreases the pumping action of the heart. This may cause a backup of fluid in the heart and may result in heart beat changes. When there are changes in the heart beat sometimes an implantable heart device is used to control the rate and rhythm of the heart beat. In certain heart failure cases, when the two lower chambers of the heart no longer beat in a coordinated manner, cardiac resynchronization therapy (CRT) may be prescribed. CRT is similar to a pacemaker. It is placed (implanted) under the skin of the upper chest. CRT is delivered as tiny electrical pulses to the right and left ventricles through three leads (flexible insulated wires) that are inserted through the veins to the heart. The purpose of this study is to evaluate a new lead for delivering energy to the left ventricle (bottom left chamber of the heart).

Conditions

Interventions

TypeNameDescription
DEVICEPacing LeadImplant and follow up of Model 20066 lead

Timeline

Start date
2011-07-01
Primary completion
2015-12-01
Completion
2015-12-01
First posted
2011-06-03
Last updated
2016-10-12

Locations

4 sites across 3 countries: Canada, Malaysia, Sweden

Source: ClinicalTrials.gov record NCT01365234. Inclusion in this directory is not an endorsement.